Jane Street’s CureVac CVAC Stock Holding History

Jane Street’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-10,500	Closed	-$85K	–	9280
2022 Q3	$85K	Sell	10,500 -3,900	-27%	-$45.5K	﹤0.01%	8728
2022 Q2	$194K	Sell	14,400 -59,200	-80%	-$979K	﹤0.01%	8217
2022 Q1	$1.43M	Buy	73,600 +2,900	+4%	+$57.9K	﹤0.01%	5388
2021 Q4	$2.44M	Sell	70,700 -16,800	-19%	-$676K	﹤0.01%	4077
2021 Q3	$4.79M	Sell	87,500 -138,400	-61%	-$8.34M	﹤0.01%	2809
2021 Q2	$16.6M	Buy	225,900 +175,700	+350%	+$17.6M	0.01%	1242
2021 Q1	$4.59M	Sell	50,200 -23,900	-32%	-$2.32M	﹤0.01%	2524
2020 Q4	$6.01M	Buy	+74,100	New	+$5.67M	﹤0.01%	1917

Jane Street's CVAC Position: Q1 2026 in Review

Jane Street sold out of CureVac (CVAC) in Q1 2026, closing a stake of 203,665 shares — an estimated $866K sold.

Jane Street first reported a position in CVAC in Q3 2020 and held it in 18 quarters. The position peaked at $5.09M in Q4 2020. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.

Jane Street reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
Jane Street sold 203,665 CureVac shares in Q1 2026, an estimated $866K.
Jane Street first reported a position in CureVac in Q3 2020 and held it in 18 quarters.
Jane Street's CureVac position peaked at $5.09M in Q4 2020.
0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.